Research Group of Psychoneuroendocrinology, Max Planck Institute of Psychiatry, Munich, Germany.
Biol Psychiatry. 2011 Nov 15;70(10):928-36. doi: 10.1016/j.biopsych.2011.07.023. Epub 2011 Sep 10.
The Hsp90 cochaperone FK506 binding protein 5 (FKBP5) is an established regulator of the glucocorticoid receptor (GR), and numerous genetic studies have linked it to stress-related diseases such as major depression or posttraumatic stress disorder. However, translational studies including genetic animal models are lacking.
Mice deficient of FKBP5 were generated and analyzed in comparison with wildtype littermates. They were subjected to several test paradigms characterizing their emotionality, stress reactivity, and coping behavior as well as hypothalamus-pituitary-adrenal axis function and regulation. Moreover, protein expression of GR and FKBP5 was determined in different brain structures 8 days after stress exposure. The combined dexamethasone/corticotropin-releasing hormone test was performed both in mice and healthy human subjects of different FKBP5 genotypes. The GR function was evaluated by reporter gene assays.
Under basal conditions, deletion of FKBP5 did not change exploratory drive, locomotor activity, anxiety-related behavior, stress-coping, or depression-like behavior. After exposure to different acute stressors of sufficient intensity, however, it led to a more active coping behavior. Moreover, loss of FKBP5 decreased hypothalamus-pituitary-adrenal axis reactivity and GR expression changes in response to stressors. In mice and humans, the FKBP5 genotype also determined the outcome of the dexamethasone/corticotropin-releasing hormone test.
This study in mice and humans presents FKBP5 as a decisive factor for the physiological stress response, shaping neuroendocrine reactivity as well as coping behavior. This lends strong support to the concept emerging from human studies of FKBP5 as important factor governing gene-environment interactions relevant for the etiology of affective disorders.
热休克蛋白 90 伴侣 FK506 结合蛋白 5(FKBP5)是糖皮质激素受体(GR)的一种既定调节剂,许多遗传研究将其与应激相关疾病(如重度抑郁症或创伤后应激障碍)联系起来。然而,缺乏包括遗传动物模型在内的转化研究。
生成并分析 FKBP5 缺失的小鼠,并与野生型同窝仔进行比较。对它们进行了多种测试,以确定其情绪、应激反应和应对行为以及下丘脑-垂体-肾上腺轴功能和调节。此外,在应激暴露 8 天后,还测定了不同脑结构中 GR 和 FKBP5 的蛋白表达。在不同 FKBP5 基因型的小鼠和健康人类受试者中进行了联合地塞米松/促肾上腺皮质激素释放激素测试。通过报告基因测定评估 GR 功能。
在基础条件下,缺失 FKBP5 不会改变探索性驱动、运动活性、焦虑相关行为、应激应对或抑郁样行为。然而,在暴露于足够强度的不同急性应激源后,它导致更积极的应对行为。此外,FKBP5 的缺失减少了下丘脑-垂体-肾上腺轴对应激源的反应性和 GR 表达变化。在小鼠和人类中,FKBP5 基因型也决定了地塞米松/促肾上腺皮质激素释放激素测试的结果。
这项在小鼠和人类中的研究表明 FKBP5 是生理应激反应的决定性因素,塑造了神经内分泌反应以及应对行为。这为 FKBP5 从人类研究中出现的概念提供了强有力的支持,即 FKBP5 是调节与情感障碍病因相关的基因-环境相互作用的重要因素。